HEREDITARY ANGIOEDEMA TYPE I
Clinical trials for HEREDITARY ANGIOEDEMA TYPE I explained in plain language.
Never miss a new study
Get alerted when new HEREDITARY ANGIOEDEMA TYPE I trials appear
Sign up with your email to follow new studies for HEREDITARY ANGIOEDEMA TYPE I, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a simple pill shield HAE patients from Procedure-Triggered attacks?
Disease control Not yet recruitingThis trial tests whether the drug sebetralstat can prevent swelling attacks in people with hereditary angioedema (HAE) when taken before a medical procedure. Participants aged 12 and older with HAE type I or II will take sebetralstat just before their scheduled procedure. The mai…
Matched conditions: HEREDITARY ANGIOEDEMA TYPE I
Phase: PHASE4 • Sponsor: KalVista Pharmaceuticals, Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Egyptian HAE patients to be studied for better care insights
Knowledge-focused Not yet recruitingThis study will collect information from medical records and routine clinic visits of 100 people in Egypt with hereditary angioedema (HAE) type I or II. The goal is to understand how the condition is diagnosed and managed in current medical practice. No new treatments are being t…
Matched conditions: HEREDITARY ANGIOEDEMA TYPE I
Sponsor: Takeda • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC